Mark Cuban challenges the idea that high drug prices are necessary for R&D, PBMs take away from profits, leaving less for innovation.
Mark Cuban Says Cutting PBM Fees Won’t Reduce Pharmaceutical R&D Funding: ‘Manufacturers Can Sell To Us For More’
Where Today's News Shapes Tomorrow
